Searched for
FOREIGN DRUGMAKERS
Global Markets: S.Korean shares log best quarter in nearly 30 years on chipmaker rallySouth Korean stocks celebrated their best quarter in almost three decades, driven by a phenomenal surge in chipmakers. The KOSPI index soar...- Oil slide powers India's stock benchmarks to longest weekly winning run 7 monthsIndian stock markets achieved their longest winning streak in seven months, with the Nifty 50 and BSE Sensex closing higher. Falling crude ...
- Trump's unusual stock frenzy: Portfolio shows 3,600 trades in 90 daysTrump's investment accounts saw thousands of trades totaling hundreds of millions of dollars between January and March. This feverish activ...
- South Korean shares hit record high on export surge, Nvidia optimismSouth Korean stocks surged to record highs on Monday. Strong chip exports fueled the rally, boosted by hopes of AI collaborations with Nvid...
- Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defenc...
- South Korean shares end 8% higher as Samsung hits record on pay dealSouth Korean shares surged 8% on Thursday, led by Samsung Electronics reaching a record high after a labor deal averted a strike, easing ec...
- Donald Trump's drugmaker deals may save economy $529 billion over 10 years: White HousePresident Trump's administration projects significant savings from deals with drug companies. These agreements aim to lower US prescription...
- Sun's strong gravity helps India Inc's pullSun Pharma has expanded its horizons by acquiring Organon, a notable New Jersey pharmaceutical firm. This strategic acquisition fortifies S...
- Global Markets | South Korean shares dip, but mark second weekly gain on Iran ceasefire hopesSouth Korean stocks ended lower Friday but secured a second weekly gain. Hopes for a U.S.-Iran ceasefire boosted sentiment. The Korean won ...
- Global Markets | S.Korean shares log highest close since Feb on hopes of US-Iran talksSouth Korean shares climbed to their highest close since February as optimism over renewed US-Iran talks boosted global risk sentiment and ...
- China beats India in race to attract global pharma companiesIn the past two years, cos such as GlaxoSmithkline, Novartis and Astra Zeneca have turned focus to China, promising investment worth billio...
- New policy to force cut in imported drug pricesForeign drugmakers fear they would be forced to cut prices of imported medicines by up to 90%.
- Eli Lilly's to bet on original drugs to triple sales in India over next 5 yearsUnlike other foreign drugmakers, it plans to stay away from acquisition of local firms or branded generics to boost its market share.
- MNC may need govt nod to buy local pharma firmMultinationals may have to move buyout proposals through FIPB, allowing the govt to understand the firm's rationale for buying a local firm.
- Natco may seek compulsory licence for Bayer's cancer drugNatco Pharma plans to seek a compulsory licence to make Bayer AG's Nexavar in India, invoking a provision in local laws that allows generic...
- Bristol-Myers patent plea for HIV drug rejectedIndia has rejected American drugmaker Bristol-Myers Squibb's (BMS) patent application for one of its HIV drugs, allowing local drugmakers t...
- Foreign cos asked to give price details of imported drugsThe country’s drug price regulator has asked for pricing details of drugs imported by some foreign drugmakers to find if they take advantag...
- Indian pharma alive and kickingSun Pharma has finally acquired management control in Israel’s Taro Pharma after a three-year legal battle with the company’s promoter fami...
- PMO circulates note on IPR tweaks for drug MNCsThe government is considering a set of proposals by global drugmakers that seeks certain changes in the country’s intellectual property rig...
- Drug market grows 20% in H1; foreign firms tighten holdA series of buyouts by foreign heavy weights, including Ranbaxy and Piramal Healthcare has resulted in foreign MNCs taking three slots amon...
Load More
